We used immuneeconv, an R software package, to calculate the immune score, stroma score, and microenvironment score for each of the GLNM regulators based on xCell algorithms [23]. GEPIA2 was used to evaluate the association between PD-L1 and the gene set expression level. The association between tumor-infiltrating immune cells (TIICs) across 33 cancer types and the gene set expression level was estimated via ImmuCellAI [24]. The Spearman correlation test was applied to analyze the correlation between the expression of GLNM regulators and the abundance of different immune cells.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.